Recordati S.p.A: Shareholders Approve The 2013 Accounts. Dividend EU 0.33 Per Share

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Recordati's Annual Shareholders' Meeting approved the company's 2013 financial accounts which were prepared according to IAS/IFRS. In addition, the group's consolidated statements, which were also prepared according to IAS/IFRS, were presented. The tables attached contain a summary of the 2013 financial statements. As announced on 6 March 2014 revenues are € 941.6 million (+13.7%), operating income (EBIT) is € 195.4 million (+17.0%), and net income is € 133.7 million (+12.8%). International sales account for 75.7% of total sales.

Help employers find you! Check out all the jobs and post your resume.

Back to news